Moderna eyes UK for next leg of mRNA vaccine manufacturing journey: report

Moderna has already seized domestic manufacturing opportunities in Canada, Australia and Africa. Now, the mRNA pioneer is setting its sights on the U.K.'s 'Golden Triangle' for the next leg of its vaccine journey, the Financial Times reports. The company is in late-stage talks with the U.K. to invest in local research and manufacturing, the publication said Sunday. Under the deal, Moderna would also team up with the U.K.’s National Health Service (NHS) for clinical trial work, the FT added. The plan would see Moderna hire staffers to run clinical trials with the NHS, the FT says. Additionally, the biotech would help bolster the U.K.’s pandemic preparedness by building out a manufacturing facility that could swiftly pivot to tackle emerging health threats, the publication noted.